Sterling Capital Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $151K | Sell |
1,926
-3,973
| -67% | -$311K | ﹤0.01% | 1300 |
|
|
2025
Q1 | $428K | Sell |
5,899
-351
| -6% | -$25.4K | 0.01% | 916 |
|
|
2024
Q4 | $463K | Sell |
6,250
-377
| -6% | -$27.9K | 0.01% | 954 |
|
|
2024
Q3 | $437K | Buy |
+6,627
| New | +$437K | 0.01% | 931 |
|
|
2018
Q4 | – | Sell |
-124,752
| Closed | -$7.24M | – | 869 |
|
|
2018
Q3 | $7.24M | Hold |
124,752
| – | – | 0.07% | 217 |
|
|
2018
Q2 | $6.05M | Hold |
124,752
| – | – | 0.06% | 224 |
|
|
2018
Q1 | $5.8M | Buy |
124,752
+6,618
| +6% | +$308K | 0.05% | 234 |
|
|
2017
Q4 | $4.44M | Buy |
118,134
+42,081
| +55% | +$1.58M | 0.04% | 267 |
|
|
2017
Q3 | $2.77M | Buy |
76,053
+4,413
| +6% | +$161K | 0.03% | 330 |
|
|
2017
Q2 | $2.82M | Buy |
71,640
+37,347
| +109% | +$1.47M | 0.03% | 312 |
|
|
2017
Q1 | $1.08M | Buy |
+34,293
| New | +$1.08M | 0.01% | 559 |
|
|
2016
Q1 | – | Sell |
-11,544
| Closed | -$304K | – | 933 |
|
|
2015
Q4 | $304K | Sell |
11,544
-27,744
| -71% | -$731K | ﹤0.01% | 865 |
|
|
2015
Q3 | $931K | Buy |
39,288
+10,842
| +38% | +$257K | 0.01% | 555 |
|
|
2015
Q2 | $675K | Buy |
28,446
+18,474
| +185% | +$438K | 0.01% | 538 |
|
|
2015
Q1 | $237K | Buy |
+9,972
| New | +$237K | ﹤0.01% | 822 |
|